Matthew B. Murphy, General Counsel at Nautilus Biotechnology, Inc. (NAUT), bought 20,000 shares at $0.64 ($13K) on 2025-09-04, disclosed to the SEC on 2025-09-05.
Open-market purchase of $13k NAUT by General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |